CelLBxHealth plc (AIM:CLBX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.9020
-0.0480 (-5.05%)
Mar 6, 2026, 4:21 PM GMT

CelLBxHealth Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
113331132280103
Market Cap Growth
-73.22%8.02%-76.73%-52.97%172.06%-5.04%
Enterprise Value
9191311626191
Last Close Price
0.010.100.120.501.190.48
PS Ratio
4.1111.5514.00126.36276.10134.91
PB Ratio
0.921.791.333.286.942.99
P/TBV Ratio
1.192.091.513.527.603.34
EV/Sales Ratio
3.506.785.96111.70257.91118.93
Debt / Equity Ratio
0.310.230.200.130.060.04
Net Debt / Equity Ratio
-0.14-0.34-0.51-0.67-0.73-0.79
Net Debt / EBITDA Ratio
0.100.440.631.101.862.32
Net Debt / FCF Ratio
0.140.450.771.511.883.30
Asset Turnover
0.100.100.050.020.020.02
Inventory Turnover
1.081.161.390.630.770.88
Quick Ratio
2.634.244.766.787.548.37
Current Ratio
3.135.045.387.368.018.72
Return on Equity (ROE)
-87.18%-68.75%-63.91%-53.95%-40.21%-38.09%
Return on Assets (ROA)
-39.98%-33.02%-30.57%-32.78%-24.22%-22.65%
Return on Capital Employed (ROCE)
-109.40%-67.40%-72.80%-57.10%-39.50%-35.80%
Earnings Yield
-146.17%-43.03%-65.78%-16.49%-5.37%-11.29%
FCF Yield
-107.63%-41.88%-49.24%-13.51%-5.61%-8.04%
Buyback Yield / Dilution
-22.34%-13.23%-5.63%-9.55%-26.42%-8.77%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.